CLARKE JOHN K 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jun 22, 2018
Insider Transaction Report
Form 4
CLARKE JOHN K
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-20+9,000→ 9,000 totalExercise: $105.26From: 2019-06-20Exp: 2028-06-19→ Common Stock (9,000 underlying)